EU releases 144 mn euro for new rare disease research

February 28, 2013

The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.

The funding will go to 26 research projects in 29 countries "in Europe and beyond" to better diagnose and treat cardiovascular, metabolic and immunological disorders, the European Commission said.

"Most affect children and most of them are devastating genetic disorders resulting in greatly reduced quality of life and premature death," said the EU commissioner for research and innovation Maire Geoghegan-Quinn.

"We hope that these new research projects will bring patients, their families and health professionals closer to a cure and support them in their daily battle with disease."

Among the different projects are a new "bioartificial" liver support system to treat , powerful data processing to develop novel diagnostic tools, biomarkers and screening strategies for therapeutic agents against rare kidney diseases, and the clinical development of a drug to treat alkaptonuria, a genetic disorder which leads to a severe and early-onset form of arthritis, heart disease and disability for which there is currently no effective treatment.

Many of the new projects will contribute to the International Rare Diseases (IRDiRC), the biggest collective rare diseases research effort world-wide.

A disease is defined as rare in Europe when it affects not more than 1 in every 2,000 people.

But because there are between 6,000 to 8,000 rare diseases, together they affect a significant share of the population.

Most rare diseases have whilst others are the result of infections, allergies and environmental causes. They are usually chronically debilitating or even life-threatening.

Explore further: Guidelines on rare diseases: Methods on handling evidence neither identified nor required

Related Stories

What is the cost of rare diseases such as Friedreich's Ataxia?

February 27, 2013

What is the cost of rare diseases such as Friedreich's Ataxia? By analyzing direct and indirect costs of care research in BioMed Central's open access journal Orphanet Journal of Rare Diseases calculated that conservatively ...

Recommended for you

Genome-editing 'toolbox' targets multiple genes at once

July 26, 2016

A Yale research team has designed a system to modify, or edit, multiple genes in the genome simultaneously, while also minimizing unintended effects. The gene-editing "toolbox" provides a user-friendly solution that scientists ...

New genetic clues into motor neuron disease

July 26, 2016

Researchers at The University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease (MND), opening the door for targeted treatments.

Chinese team to pioneer first human CRISPR trial

July 22, 2016

(Medical Xpress)—A team of researchers at Sichuan University's West China Hospital has announced plans to begin a clinical trial where cells modified using the CRISPR gene editing technique will be used on human beings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.